Cepheid and Oxford Nanopore Expand Partnership for Infectious Disease Genomics
Sunnyvale-based Cepheid and UK-based Oxford Nanopore Technologies have expanded their partnership to advance genomic workflows for infectious disease research, announced in a press release.
The second phase of their collaboration focuses on developing a workflow for rapid identification of bacterial and fungal pathogens, building on progress from the first phase introduced at the ESCMID Global 2025 conference. The new workflow will support pathogen identification, antimicrobial resistance profiling, and genomic antibiotic susceptibility testing predictions for bloodstream infection and sepsis research.
This phase will include product design enhancements and a co-commercialized research use only (RUO) launch to expand accessibility. The workflow will operate on Cepheid’s GeneXpert platform combined with Oxford Nanopore’s sequencing technology to streamline genomic analysis from both culture isolates and positive blood cultures.
Early beta access is already available to select research groups, with broader early access planned for the third quarter of 2026. Both companies are presenting their progress at ESCMID Global this week.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
INmune Bio and QCi Apply Quantum Computing to XPro Research
Illumina Launches BioInsight Platform for Genomic Research
XtalPi Launches Kodexia siRNA Discovery Platform
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
MyOme Expands Genomic Risk Platform Worldwide on Oracle Cloud
Daily AI Brief: the AI news that matters, in your inbox.